Cargando…

Hippocampal Deficits in Amyloid-β-Related Rodent Models of Alzheimer’s Disease

Alzheimer’s disease (AD) is a progressive neurodegenerative disease that is the most common cause of dementia. Symptoms of AD include memory loss, disorientation, mood and behavior changes, confusion, unfounded suspicions, and eventually, difficulty speaking, swallowing, and walking. These symptoms...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vyas, Yukti, Montgomery, Johanna M., Cheyne, Juliette E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154147/ https://www.ncbi.nlm.nih.gov/pubmed/32317913 http://dx.doi.org/10.3389/fnins.2020.00266

Ejemplares similares

Shankopathies in the Developing Brain in Autism Spectrum Disorders
por: Vyas, Yukti, et al.
Publicado: (2021)

In vitro zinc supplementation alters synaptic deficits caused by autism spectrum disorder-associated Shank2 point mutations in hippocampal neurons
por: Vyas, Yukti, et al.
Publicado: (2021)

Recording plasticity in neuronal activity in the rodent intrinsic cardiac nervous system using calcium imaging techniques
por: Smith, Joscelin E. G., et al.
Publicado: (2023)

Sex differences in hippocampal β-amyloid accumulation in the triple-transgenic mouse model of Alzheimer’s disease and the potential role of local estrogens
por: Hu, Yu-Ting, et al.
Publicado: (2023)

Dietary Zinc Supplementation Prevents Autism Related Behaviors and Striatal Synaptic Dysfunction in Shank3 Exon 13–16 Mutant Mice
por: Fourie, Chantelle, et al.
Publicado: (2018)

Erratum: Sex differences in hippocampal β-amyloid accumulation in the triple-transgenic mouse model of Alzheimer's disease and the potential role of local estrogens
Publicado: (2023)

Influence of maternal zinc supplementation on the development of autism-associated behavioural and synaptic deficits in offspring Shank3-knockout mice
por: Vyas, Yukti, et al.
Publicado: (2020)

β-Amyloid oligomers in aging and Alzheimer’s disease
por: Zahs, Kathleen R., et al.
Publicado: (2013)

Persistent deficits in hippocampal synaptic plasticity accompany losses of hippocampus-dependent memory in a rodent model of psychosis
por: Wiescholleck, Valentina, et al.
Publicado: (2013)

Auditory processing in rodent models of autism: a systematic review
por: Wilde, Maya, et al.
Publicado: (2022)

Neuroplastin 65 deficiency reduces amyloid plaque formation and cognitive deficits in an Alzheimer’s disease mouse model
por: Wu, Dan-Dan, et al.
Publicado: (2023)

A review of β-amyloid neuroimaging in Alzheimer's disease
por: Adlard, Paul A., et al.
Publicado: (2014)

The Early Events That Initiate β-Amyloid Aggregation in Alzheimer’s Disease
por: Zhang, Xingyu, et al.
Publicado: (2018)

Ethanol Alleviates Amyloid-β-Induced Toxicity in an Alzheimer’s Disease Model of Caenorhabiditis elegans
por: Bai, Shuju, et al.
Publicado: (2021)

The low-density lipoprotein receptor-related protein 1 and amyloid-β clearance in Alzheimer’s disease
por: Kanekiyo, Takahisa, et al.
Publicado: (2014)

Extracellular Sortilin Proteopathy Relative to β-Amyloid and Tau in Aged and Alzheimer’s Disease Human Brains
por: Tu, Tian, et al.
Publicado: (2020)

Homozygous knockout of eEF2K alleviates cognitive deficits in APP/PS1 Alzheimer’s disease model mice independent of brain amyloid β pathology
por: Kasica, Nicole P., et al.
Publicado: (2022)

Anti-Aβ Autoantibodies in Amyloid Related Imaging Abnormalities (ARIA): Candidate Biomarker for Immunotherapy in Alzheimer’s Disease and Cerebral Amyloid Angiopathy
por: DiFrancesco, Jacopo C., et al.
Publicado: (2015)

The role of postsynaptic density proteins in neural degeneration and regeneration
por: Vyas, Yukti, et al.
Publicado: (2016)

Modulation of β-Amyloid Fibril Formation in Alzheimer’s Disease by Microglia and Infection
por: Brown, Madeleine R., et al.
Publicado: (2020)

Plasma Exosomes Spread and Cluster Around β-Amyloid Plaques in an Animal Model of Alzheimer’s Disease
por: Zheng, Tingting, et al.
Publicado: (2017)

Hippocampal Injections of Oligomeric Amyloid β-peptide (1–42) Induce Selective Working Memory Deficits and Long-lasting Alterations of ERK Signaling Pathway
por: Faucher, Pierre, et al.
Publicado: (2016)

Structural rearrangement of amyloid-β upon inhibitor binding suppresses formation of Alzheimer’s disease related oligomers
por: Lieblein, Tobias, et al.
Publicado: (2020)

Amelioration of amyloid-β-induced deficits by DcR3 in an Alzheimer’s disease model
por: Liu, Yi-Ling, et al.
Publicado: (2017)

Age and Alzheimer’s Disease-Related Oligodendrocyte Changes in Hippocampal Subregions
por: DeFlitch, Leah, et al.
Publicado: (2022)

Induction of A Disintegrin and Metalloproteinase with Thrombospondin motifs 1 by a rare variant or cognitive activities reduces hippocampal amyloid-β and consequent Alzheimer’s disease risk
por: Qiu, Yunjie, et al.
Publicado: (2022)

Comparative Hippocampal Synaptic Proteomes of Rodents and Primates: Differences in Neuroplasticity-Related Proteins
por: Koopmans, Frank, et al.
Publicado: (2018)

mGluR-dependent plasticity in rodent models of Alzheimer’s disease
por: Valdivia, Gonzalo, et al.
Publicado: (2023)

Spatial memory deficits in a mouse model of late-onset Alzheimer’s disease are caused by zinc supplementation and correlate with amyloid-beta levels
por: Flinn, Jane M., et al.
Publicado: (2014)

EGCG Nanoparticles Attenuate Aluminum Chloride Induced Neurobehavioral Deficits, Beta Amyloid and Tau Pathology in a Rat Model of Alzheimer’s Disease
por: Singh, Neha Atulkumar, et al.
Publicado: (2018)

Soluble amyloid-β oligomers as synaptotoxins leading to cognitive impairment in Alzheimer’s disease
por: Ferreira, Sergio T., et al.
Publicado: (2015)

Clearance of amyloid β-protein and its role in the spreading of Alzheimer's disease pathology
por: Thal, Dietmar R.
Publicado: (2015)

Editorial: Clearance Pathways for Amyloid-β. Significance for Alzheimer's Disease and Its Therapy
por: Carare, Roxana O.
Publicado: (2017)

Hyperactivity Induced by Soluble Amyloid-β Oligomers in the Early Stages of Alzheimer's Disease
por: Hector, Audrey, et al.
Publicado: (2021)

Insights Into the Mechanism of Tyrosine Nitration in Preventing β-Amyloid Aggregation in Alzheimer’s Disease
por: Zhao, Jie, et al.
Publicado: (2021)

Spatial Distribution and Hierarchical Clustering of β-Amyloid and Glucose Metabolism in Alzheimer’s Disease
por: Zhou, Da-An, et al.
Publicado: (2022)

Reconsidering hippocampal neurogenesis in Alzheimer's disease
por: Martinez-Canabal, Alonso
Publicado: (2014)

How do Soluble Oligomers of Amyloid β-protein Impair Hippocampal Synaptic Plasticity?
por: Li, Shaomin, et al.
Publicado: (2010)

Affibody-Mediated Sequestration of Amyloid β Demonstrates Preventive Efficacy in a Transgenic Alzheimer’s Disease Mouse Model
por: Boutajangout, Allal, et al.
Publicado: (2019)

Evaluation of Synapse Density in Hippocampal Rodent Brain Slices
por: McLeod, Faye, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_op8ivau24lj4fj89mlcmctbs2c